HealthcareServices

Chronic Kidney Disease Market Research: Growth Projections and Trends 2030

February 23, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the chronic kidney disease market from 2026–2035 with trusted insights from The Business Research Company

What growth pattern is forecast for the Chronic Kidney Disease Market size between 2026 and 2035?

The market size for chronic kidney disease has witnessed substantial growth in recent years. It is anticipated to expand from $74.87 billion in 2025 to $79.43 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.1%. Historical growth can be attributed to the rising incidence of diabetes and hypertension, enhanced accessibility to dialysis infrastructure, advancements in kidney function diagnostics, increased understanding of chronic renal disorders, and the expansion of nephrology care services.

The chronic kidney disease market is anticipated to experience substantial expansion over the coming years. This market is projected to reach $101.87 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 6.4%. Several factors are expected to fuel this growth during the forecast period, including the accelerated development of innovative renal treatments, a heightened demand for patient-focused dialysis solutions, the spread of digital monitoring for kidney health, an increased emphasis on preparing for transplants, and greater financial commitments to preventive nephrology. Key trends anticipated during this period encompass a stronger focus on identifying chronic kidney disease early, the increasing uptake of medications designed to protect kidney function, a broader implementation of home-based dialysis methods, the growth of integrated care approaches involving multiple specialties, and a concentrated effort to decelerate the disease’s advancement.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11969&type=smp

Which Drivers Are Impacting Market Performance In The Chronic Kidney Disease Market?

The rising occurrence of kidney disease is anticipated to drive the expansion of the chronic kidney disease market in the future. These diseases encompass various conditions that impair the kidneys’ structure and ability to function. Therapeutics for kidney disease are administered to regulate patient blood pressure and reduce protein leakage, thereby slowing the advancement of kidney damage, alleviating symptoms, and preventing complications. For instance, in June 2023, Kidney Research UK, a UK-based, charity dedicated to funding research into kidney disease, reported that by 2033, the population affected by CKD stages 3–5 is expected to rise to around 3.9 million. Consequently, the growing incidence of kidney disease is fueling the expansion of the chronic kidney disease market.

Which Segments Are Contributing To The Growth Of The Chronic Kidney Disease Market?

The chronic kidney disease market covered in this report is segmented –

1) By Diagnosis: Blood Test, Urine Test, Imaging Test, Kidney Biopsy

2) By Treatment: Drugs, Dialysis, Kidney Transplant, ACE Inhibitors, Blood Test, Other Treatments

3) By Route of Administration: Oral, Intravenous, Subcutaneous

4) By End-User: Hospital And Clinics, Ambulatory Surgery Centers (ASCs), Dialysis Centers, Other End-Users

Subsegments:

1) By Blood Test: Serum Creatinine Test, Glomerular Filtration Rate (GFR) Test, Blood Urea Nitrogen (BUN) Test, Electrolyte Tests

2) By Urine Test: Urinalysis, 24-hour Urine Collection, Urine Protein Test, Urine Albumin-To-Creatinine Ratio (ACR)

3) By Imaging Test: Ultrasound, CT Scan, MRI, X-Ray

4) By Kidney Biopsy: Percutaneous Kidney Biopsy, Open Kidney Biopsy, Laparoscopic Kidney Biopsy

What Long-Term Trends Are Expected To Shape The Future Of The Chronic Kidney Disease Market?

Leading firms operating in the chronic kidney disease market are adopting strategic partnerships to study the safety and efficacy of an improved Automated Wearable Artificial Kidney Peritoneal Dialysis (AWAK PD) device. Such strategic partnerships entail a process where companies leverage each other’s strengths and resources to achieve mutual benefits and success. As an illustration, in June 2023, AWAK Technologies Pte Ltd., a Singapore-based medical technology company, collaborated with Singapore General Hospital Pte Ltd. (SGH), a Singapore-based academic health science center and hospital company. Through this partnership, they intend to revolutionize the diagnosis, treatment, and management of kidney disease, which includes the development and testing of a wearable and ultra-portable peritoneal dialysis (PD) system, known as AWAK PD, enabling patients with end-stage kidney disease to undergo dialysis at home and on the go.

Who Are The Core Companies Influencing Trends In The Chronic Kidney Disease Market?

Major companies operating in the chronic kidney disease market are Pfizer Inc, Johnson and Johnson Services Inc., F. Hoffmann-La Roche Ltd., AbbVie Inc., Bayer AG, Novartis International AG, Sanofi SA, Bristol-Myers Squibb Company, Abbott laboratories Inc., GlaxoSmithKline PLC, Takeda Pharmaceuticals Ltd., Eli Lilly and Company, Boehringer Ingelheim International GmbH, Amgen Inc., Novo Nordisk AS, Siemens Healthineers AG, AstraZeneca Pharmaceuticals LP, Teva Pharmaceutical Industries Ltd., Beckman Coulter Inc., Kissei Pharmaceutical Co. Ltd., Akebia Therapeutics Inc., Tricida Inc., Regulus Therapeutics Inc., Goldfinch Bio Co, Alio Inc., Monogram Health, Strive Health, Maze Therapeutics, ProKidney Corp

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/chronic-kidney-disease-global-market-report

Which Geographic Areas Are Emerging As Strong Markets For The Chronic Kidney Disease Market?

North America was the largest region in the chronic kidney disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic kidney disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Chronic Kidney Disease Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=11969&type=smp

Browse Through More Reports Similar to the Global Chronic Kidney Disease Market 2026, By The Business Research Company

Late Stage Chronic Kidney Disease Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/late-stage-chronic-kidney-disease-drugs-global-market-report

Kidney Disease Market Report 2026

https://www.thebusinessresearchcompany.com/report/kidney-disease-global-market-report

Diabetic Kidney Disease Market Report 2026

https://www.thebusinessresearchcompany.com/report/diabetic-kidney-disease-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795